Eastman Chemical (EMN) beats Q2 2026 EPS by 8.2% on surging Chemical Intermediates

Eastman Chemical reported Q2 2026 earnings per share of $1.97, topping Wall Street's $1.82 estimate by 8.2%, while revenue of $2.51 billion cleared expectations of roughly $2.40 billion by nearly 5%. The standout driver was the Chemical Intermediates segment, which swung from a $30 million loss a year ago to a $58 million profit — a turnaround fueled by 39% revenue growth as Middle East supply disruptions pushed both prices and volumes higher.

Beyond that segment-level reversal, sequential margins expanded 350 basis points, reflecting disciplined pricing in Eastman's specialty businesses. The combination of a major year-over-year earnings beat, a clean revenue surprise, and improving margins marks a meaningful step up from the weaker results the company posted through much of 2025, when reported EPS fell short of estimates in Q2 and Q3 of that year.

The picture is not entirely clear, however. Management trimmed full-year cash flow guidance to $900 million, citing inflationary pressure on receivables. That revision is the key variable investors will be watching as they assess whether the Q2 momentum can hold through the back half of 2026.